US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Global Healthcare ETF

100.86

-0.0700-0.07%

Post-market: 100.60-0.2580-0.26%19:30 EDT

Volume:93.70K

Turnover:9.44M

Market Cap:4.25B

PE:-98.08

High:101.04

Open:101.04

Low:100.34

Close:100.93

52wk High:107.69

52wk Low:90.24

Shares:42.15M

Float Shares:42.15M

Volume Ratio:0.79

T/O Rate:0.22%

Dividend:1.38

Dividend Rate:1.37%

EPS(TTM):-1.0283

EPS(LYR):-1.0283

ROE:-8.66%

ROA:0.90%

PB:1.10

PE(LYR):-98.08

Loading ...

Overview Company News Filings

Esperion Therapeutics Offers Short-Term Option for Diuretic Management Before Escalation to IV for Patients With Heart Failure

Moderna Stock Has Run Too Far, Too Fast. Why Citi Just Downgraded it to Sell

Kenvue Says Post-Hoc Phase III Analysis Links Earlier 5% Minoxidil Use to Higher Hair Regrowth in Men with Androgenetic Alopecia

Venture Life CFO increases personal stake with share purchase

Marka S.A. Pays Twelfth Installment Under Amended Bondholder Arrangement

Johnson & Johnson Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Benzinga Earnings

AbbVie reports ‘positive’ results from Phase 2 APEX Part B study of zumilokibart

AbbVie Starts Phase 2 Obesity Trial of Gubra-Discovered Amylin Analog ABBV-295

Abbvie: in Phase 1 Abbv-295 Study, All Dosing Regimens Resulted in Ls Mean Weight Loss up to About 10% over 3-Month Treatment Period

THOMSON REUTERS

Abbvie: 82.2% of All Abbv-295 Treated Participants Reported Mild Adverse Events as Highest Reported Ae Severity

THOMSON REUTERS

AbbVie Says Phase 1 ABBV-295 Study Shows Mean Weight Loss up to About 10% over 3-Month Period

AbbVie Says Mid-Stage Study of Atopic Dermatitis Treatment Meets Primary Goal

MT Newswires Live

Abbvie Highlights Positive Results from the Phase 2 Apex Part B Study of Zumilokibart in Moderate to Severe Atopic Dermatitis, as a Late Breaker at Eadv 2026

THOMSON REUTERS

AbbVie Presents Phase 2 APEX Part B Data for Zumilokibart in Moderate-to-Severe Atopic Dermatitis at EADV 2026

Eli Lilly reports results from TRIUMPH-2 Phase 3 trial

Lilly's Experimental Drug Cuts Weight by 21% in Diabetes Trial

Eli Lilly - Retatrutide 12 Mg Results in 49.6 Lb (20.8%) Weight Loss over 80 Weeks

THOMSON REUTERS

Lilly's Triple Agonist, Retatrutide, Delivered Substantial Weight Loss and A1c Reduction, Underscoring Its Potential Promise for People with Obesity and Type 2 Diabetes

THOMSON REUTERS

Eli Lilly - to Submit Biologics License Application for Retatrutide in Q1 2027

THOMSON REUTERS

Eli Lilly - 59.5% of Retatrutide 12 Mg Participants no Longer Meet Bmi Criteria for Obesity

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/IXJ/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IXJ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IXJ\",,,,,undefined,":{"symbol":"IXJ","market":"US","secType":"STK","nameCN":"iShares Global Healthcare ETF","latestPrice":100.86,"timestamp":1790971200000,"preClose":100.93,"halted":0,"volume":93702,"hourTrading":{"tag":"盘后","latestPrice":100.602,"preClose":100.86,"latestTime":"19:30 EDT","volume":1076,"amount":108265.726,"timestamp":1790983804657,"change":-0.258,"changeRate":-0.002558,"amplitude":0.002657},"delay":0,"changeRate":-0.0006935499851382878,"floatShares":42150000,"shares":42150000,"eps":-1.028295,"marketStatus":"Market Closed","change":-0.07,"latestTime":"10-02 16:00:00 EDT","open":101.04,"high":101.04,"low":100.335,"amount":9441487.54458,"amplitude":0.006985,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":-1.028295,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":100.93,"sharesOutstanding":41150000,"nav":100.818098,"aum":4259564640.5,"dividendRate":0.013655,"bidAskSpread":0.001607,"preHourTrading":{"tag":"盘前","latestPrice":100.93,"preClose":100.93,"latestTime":"08:47 EDT","volume":3,"amount":302.79,"timestamp":1790945228115,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":100.602,"preClose":100.86,"latestTime":"19:30 EDT","volume":1076,"amount":108265.726,"timestamp":1790983804657,"change":-0.258,"changeRate":-0.002558,"amplitude":0.002657},"volumeRatio":0.791795250604619,"impliedVol":0.0292,"impliedVolPercentile":0.2072},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IXJ\",,,,,undefined,":{"symbol":"IXJ","floatShares":42150000,"roa":"0.90%","roe":"-8.66%","lyrEps":-1.028295,"volumeRatio":0.791795250604619,"shares":42150000,"dividePrice":1.377253,"high":101.04,"amplitude":0.006985,"preClose":100.93,"low":100.335,"week52Low":90.24,"pbRate":"1.10","psRate":"57.44","week52High":107.685,"institutionHeld":0,"latestPrice":100.86,"eps":-1.028295,"divideRate":0.013655,"volume":93702,"delay":0,"ttmEps":-1.028295,"open":101.04,"prevYearClose":97.4,"prevWeekClose":103.88,"prevMonthClose":102.12,"prevQuarterClose":102.12,"fiveDayClose":103.88,"twentyDayClose":106.05,"sixtyDayClose":99.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IXJ\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IXJ","amount":0.846056,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"全球医疗业ETF-iShares","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2025-12-16","symbol":"IXJ","amount":0.597646,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"全球医疗业ETF-iShares","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"IXJ","amount":0.762798,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"全球医疗业ETF-iShares","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"IXJ","amount":0.61725,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"全球医疗业ETF-iShares","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"IXJ","amount":0.67232,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"全球医疗业ETF-iShares","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IXJ\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.724079,"currency":"USD"},{"executeDate":"2017-06-20","recordDate":"2017-06-22","paymentDate":"2017-06-26","value":0.987716,"currency":"USD"},{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-25","value":0.517509,"currency":"USD"},{"executeDate":"2018-12-18","recordDate":"2018-12-19","paymentDate":"2018-12-24","value":0.347433,"currency":"USD"},{"executeDate":"2018-12-28","recordDate":"2018-12-31","paymentDate":"2019-01-04","value":0.33206,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IXJ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IXJ\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671014612","title":"Esperion Therapeutics Offers Short-Term Option for Diuretic Management Before Escalation to IV for Patients With Heart Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2671014612","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671014612?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:00","pubTimestamp":1790769600,"startTime":"0","endTime":"0","summary":"– Loop Diuretic Route of Administration Option Is Delivered As A Single-Use Nasal Spray – – Nasal Route Offers a Direct Path to Systemic Absorption Without Relying on the GI Tract – ANN ARBOR, Mich., ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/30/3371833/0/en/esperion-therapeutics-offers-short-term-option-for-diuretic-management-before-escalation-to-iv-for-patients-with-heart-failure.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2637428348.USD","LU0545039389.USD","ESPR","BK4550","CMS","CGCV","LU1003077747.HKD","IXJ","LU1894683348.USD","BK4208","LU0553294199.USD","BK4588","VHT","BK4007","LU1894683264.USD","NOBL","BK4585","LU0738911758.USD","LU0949170772.SGD","BK4188","TCAF","LU2346227817.USD","LU2500361329.USD","ASM","LU0661504455.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671481209","title":"Moderna Stock Has Run Too Far, Too Fast. Why Citi Just Downgraded it to Sell","url":"https://stock-news.laohu8.com/highlight/detail?id=2671481209","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671481209?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:42","pubTimestamp":1790768520,"startTime":"0","endTime":"0","summary":"Moderna's eye-watering rally has officially outpaced its fundamentals, according to one analyst, prompting a downgrade at a major Wall Street firm.Citi's Geoff Meacham cut his rating on Moderna shares","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","BMED","GNOM","RXL","TRUH","XLV","IXJ","IHE","PPH","WDNA","MRNA","HRTS","MRNY","GDOC","FTXH","IDNA","FHLC","PAWZ","VHT","LGHT","IYH","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671205985","title":"Kenvue Says Post-Hoc Phase III Analysis Links Earlier 5% Minoxidil Use to Higher Hair Regrowth in Men with Androgenetic Alopecia","url":"https://stock-news.laohu8.com/highlight/detail?id=2671205985","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671205985?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:45","pubTimestamp":1790765154,"startTime":"0","endTime":"0","summary":"Kenvue says post-hoc Phase III analysis links earlier 5% minoxidil use to higher hair regrowth in men with androgenetic alopeciaKenvue outlined new clinical and preclinical findings slated for present","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL8jHf4f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1003077747.HKD","LU2471134796.USD","LU2487616109.SGD","IE00B2B36J28.USD","TRUH","LU2236285917.USD","JDOC","IE00B4R5TH58.HKD","VHT","SG9999001176.SGD","JNJ","BK4581","RXL","MEDX","IYH","SG9999001440.SGD","IXJ","LU0787776722.HKD","IE00BVYPNV92.GBP","IE0002141913.USD","IE000WAW04H5.SGD","LU1196500208.SGD","RSPS","LU1032955483.USD","FHLC","LU1778281490.HKD","GLAM","LU1145028129.USD","LU0792757196.USD","LU2089984988.USD","IHE","PJP","LU1894683348.USD","LU0689626769.HKD","LU0738911758.USD","LU1267930573.SGD","LU1244550221.USD","SG9999001176.USD","GDOC","LU0345770308.USD","LU0289739699.SGD","LU0661504455.SGD","LU0912757837.SGD","XLV","BMED","LU0128525929.USD","FTXH","LU2471134952.CNY","KVUE","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671205376","title":"Venture Life CFO increases personal stake with share purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2671205376","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671205376?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:22","pubTimestamp":1790763742,"startTime":"0","endTime":"0","summary":"Venture Life ( ($GB:VLG) ) has provided an update. Venture Life Group, a specialist in consumer self-care healthcare products ranging from women’s ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/venture-life-cfo-increases-personal-stake-with-share-purchase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/venture-life-cfo-increases-personal-stake-with-share-purchase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IXJ","CGCV","TCAF","VHT","BK4585","NOBL","BK4550","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671205594","title":"Marka S.A. Pays Twelfth Installment Under Amended Bondholder Arrangement","url":"https://stock-news.laohu8.com/highlight/detail?id=2671205594","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671205594?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:18","pubTimestamp":1790763483,"startTime":"0","endTime":"0","summary":"An update from Marka SA ( ($PL:MRK) ) is now available. Marka S.A. has notified investors that it has executed the twelfth installment under its am...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/marka-s-a-pays-twelfth-installment-under-amended-bondholder-arrangement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/marka-s-a-pays-twelfth-installment-under-amended-bondholder-arrangement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1430594728.SGD","PAWZ","LU0265550946.USD","LU0162691827.USD","IE00BSNM7G36.USD","LU0942090050.USD","LU1093756168.USD","SG9999015358.SGD","JDOC","LU0868494708.USD","IXJ","LU1941712264.USD","IHE","HRTS","LU0823416689.USD","VHT","BK4585","LU2468319806.SGD","FHLC","XLV","LU0203345920.USD","LU1162221912.USD","SGXZ57979304.SGD","SG9999014567.USD","LU2361045086.USD","LU0069063385.USD","LU1057294990.SGD","BMED","FTXH","LU0472753341.HKD","LU1699723380.USD","IE00BN8TJ469.HKD","MRK","BK4533","GDOC","TRUH","LU0070302665.USD","LU2125154935.USD","IE00B1BXHZ80.USD","LU0058720904.USD","LU2125154778.USD","SG9999002224.SGD","LU0432979614.USD","LU1571399168.USD","LU1989772840.SGD","BK4559","PPH","RXL","IYH","LU0689626769.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671082132","title":"Johnson & Johnson Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2671082132","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671082132?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:05","pubTimestamp":1790762710,"startTime":"0","endTime":"0","summary":"Johnson &amp; Johnson reports Q3 earnings Oct. 13; EPS seen at $2.48, revenue $25.31B. Analysts are mostly bullish after positive Tremfya and Carvykti data.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/09/62072451/johnson-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts-5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1221951129.SGD","BK4585","LU0122379950.USD","SG9999013999.USD","LU2471134523.USD","JDOC","IE000F7OJYX1.SGD","LU1506573853.SGD","LU1585245621.USD","LU1059921491.USD","TRUH","IE00B19Z3581.USD","IE0002141913.USD","MEDX","RXL","LU1196500208.SGD","BMED","LU2213496289.HKD","LU1221951046.USD","SG9999001176.SGD","PJP","IHE","FTXH","XLV","GDOC","LU0320765646.SGD","IYH","IE00BVYPNW00.USD","FHLC","BK4592","LU1551013342.USD","LU2505996509.AUD","VHT","LU0072461881.USD","LU0234572021.USD","LU1983299246.USD","IE00BJT1NW94.SGD","LU0234570918.USD","LU0345769631.USD","LU0820561818.USD","JNJ","LU2468319806.SGD","LU0511384066.AUD","LU0787776722.HKD","IXJ","LU1929549753.HKD","LU0545039389.USD","LU1023059063.AUD","LU2456880835.USD","LU1043141123.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671089252","title":"AbbVie reports ‘positive’ results from Phase 2 APEX Part B study of zumilokibart","url":"https://stock-news.laohu8.com/highlight/detail?id=2671089252","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671089252?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:55","pubTimestamp":1790762110,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV) announced that the primary results from the ongoing Phase 2 APEX Part B Dose-Regimen-Finding Study, evaluating zumilokibart, in adult...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abbvie-reports-positive-results-from-phase-2-apex-part-b-study-of-zumilokibart-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abbvie-reports-positive-results-from-phase-2-apex-part-b-study-of-zumilokibart-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","IE000F7OJYX1.SGD","LU0234572021.USD","VHT","IE00BLSP4452.SGD","BK4550","LU0029864427.USD","LU0395794307.EUR","LU0553294199.USD","LU0256863811.USD","FTXH","AGNG","PJP","LU1732800096.USD","LU2023251221.USD","LU2347655073.USD","RXL","IXJ","LU1430594728.SGD","LU2089284900.SGD","LU1057294990.SGD","LU1720051108.HKD","PPH","LU1989772923.USD","IE00B2B36J28.USD","IE0002141913.USD","LU1037948541.HKD","IE00B19Z3581.USD","ABBV","IYH","LU0114720955.EUR","LU0203345920.USD","LU0472753341.HKD","LU2347655156.SGD","MEDX","LU0820561909.HKD","LU0057025933.USD","LU1670628061.USD","BK4533","IE000SO60NU8.SGD","LU1934455277.USD","IE00B3PB1722.GBP","IE0000B7K699.USD","GLAM","JDOC","IE00BJJMRZ35.SGD","XLV","TRUH","LU0058720904.USD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671208859","title":"AbbVie Starts Phase 2 Obesity Trial of Gubra-Discovered Amylin Analog ABBV-295","url":"https://stock-news.laohu8.com/highlight/detail?id=2671208859","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671208859?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:51","pubTimestamp":1790761876,"startTime":"0","endTime":"0","summary":"AbbVie starts Phase 2 obesity trial of Gubra-discovered amylin analog ABBV-295Gubra flagged AbbVie’s detailed Phase 1 results for obesity candidate ABBV-295, presented at EASD 2026 in Milan.Data showe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL9BGxfn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0912757837.SGD","MEDX","VHT","LU0417517546.SGD","LU1934455863.HKD","IYH","LU1037948541.HKD","JDOC","LU2112291526.USD","FHLC","TRUH","IE00B4R5TH58.HKD","LU0289961442.SGD","IXJ","LU0069063385.USD","LU1718418525.SGD","LU0820561909.HKD","LU1923622614.USD","LU0170899867.USD","LU2237443622.USD","PJP","LU0985320562.USD","PPH","SG9999015952.SGD","LU0310799852.SGD","LU0289739343.SGD","IE00BJT1NW94.SGD","LU0708994859.HKD","RXL","ABBV","LU2237443978.SGD","LU1430594728.SGD","LU1989772923.USD","GLAM","FTXH","LU0310800379.SGD","LU1037948897.HKD","IE00BVYPNV92.GBP","LU1983299246.USD","XLV","LU1267930490.SGD","LU0859254822.USD","LU0456855351.SGD","LU0661504455.SGD","LU0058720904.USD","LU0738911758.USD","LU1093756168.USD","AGNG","LU2125909247.SGD","LU2357305700.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671270785","title":"Abbvie: in Phase 1 Abbv-295 Study, All Dosing Regimens Resulted in Ls Mean Weight Loss up to About 10% over 3-Month Treatment Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2671270785","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671270785?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:45","pubTimestamp":1790761500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nP8N3WW07N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0395794307.EUR","IE000BZT7R73.USD","LU2087621335.USD","LU0198837287.USD","LU0320765646.SGD","LU1267930490.SGD","LU1093756168.USD","IE00BJJMRZ35.SGD","JDOC","BK4534","ABBV","IXJ","LU0820561909.HKD","VHT","XLV","FHLC","IE00BJT1NW94.SGD","LU0203345920.USD","LU1934455863.HKD","LU1236620750.USD","LU1983299246.USD","LU0057025933.USD","IE00BBT3K403.USD","MEDX","LU0124676726.USD","PJP","LU0417517546.SGD","LU0868494617.USD","FTXH","LU0203347892.USD","SG9999015952.SGD","LU1934455194.USD","IE00BGHQF631.EUR","IE0004445239.USD","LU0234570918.USD","LU0289739343.SGD","IE0002141913.USD","TRUH","LU1244550494.USD","LU1037948897.HKD","LU0058720904.USD","RXL","LU2129689431.USD","AGNG","LU0949170772.SGD","BK4559","LU1839511570.USD","GLAM","IYH","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671270207","title":"Abbvie: 82.2% of All Abbv-295 Treated Participants Reported Mild Adverse Events as Highest Reported Ae Severity","url":"https://stock-news.laohu8.com/highlight/detail?id=2671270207","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671270207?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:45","pubTimestamp":1790761500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nP8N3WW07N:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABBV","LU0128525929.USD","VHT","LU1037948897.HKD","TRUH","IE0009355771.USD","LU1244550577.SGD","LU1720051017.SGD","LU1430594728.SGD","JDOC","GLAM","PPH","SG9999015978.USD","AGNG","LU2087621335.USD","IE000SO60NU8.SGD","FHLC","BK4533","LU1732800096.USD","LU2347655156.SGD","BK4139","BK4534","LU0395794307.EUR","LU2237443549.SGD","LU1989771016.USD","LU0057025933.USD","LU1989772840.SGD","IE00BSNM7G36.USD","LU0310800379.SGD","LU2089283258.USD","LU0689626769.HKD","IE00BLSP4239.USD","LU0985320562.USD","SG9999011175.SGD","LU0943347566.SGD","IYH","RXL","LU0158827948.USD","FTXH","XLV","IXJ","LU0545039389.USD","LU0795875169.SGD","PJP","LU1267930573.SGD","IE000BZT7R73.USD","LU0289739699.SGD","MEDX","LU2357627491.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671208209","title":"AbbVie Says Phase 1 ABBV-295 Study Shows Mean Weight Loss up to About 10% over 3-Month Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2671208209","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671208209?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:45","pubTimestamp":1790761500,"startTime":"0","endTime":"0","summary":"BRIEF-AbbVie Says Phase 1 ABBV-295 Study Shows Mean Weight Loss Up To About 10% Over 3-Month PeriodSept 30 -AbbVie Inc.ABBV.N:ABBVIE: IN PHASE 1 ABBV-295 STUDY, ALL DOSING REGIMENS RESULTED IN LS MEAN WEIGHT LOSS UP TO ABOUT 10% OVER 3-MONTH TREATMENT PERIODABBVIE: 82.2% OF ALL ABBV-295 TREATED PARTICIPANTS REPORTED MILD ADVERSE EVENTS AS HIGHEST REPORTED AE SEVERITYFurther company coverage:ABBV.N","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nP8N3WW07N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1548497426.USD","LU1496350502.SGD","FTXH","MEDX","LU1670627923.USD","FHLC","PJP","ABBV","LU2087621335.USD","LU0432979614.USD","LU1983299246.USD","LU0823416689.USD","LU2089984988.USD","IE00BSNM7G36.USD","LU0965508806.USD","LU2112291526.USD","BK4566","AGNG","GLAM","LU0820561909.HKD","LU0320765646.SGD","JDOC","LU2357305700.SGD","LU1291159041.SGD","LU0098860793.USD","LU1839511570.USD","RXL","IXJ","LU0310799852.SGD","LU0310800379.SGD","SG9999015952.SGD","LU1934455277.USD","TRUH","LU1037948897.HKD","VHT","IYH","LU1732800096.USD","LU0256863902.USD","LU0689472784.USD","LU0472753341.HKD","LU1430594728.SGD","LU1093756168.USD","PPH","LU0158827948.USD","XLV","IE00BN8TJ469.HKD","LU0057025933.USD","SG9999015978.USD","IE0004445239.USD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671271707","title":"AbbVie Says Mid-Stage Study of Atopic Dermatitis Treatment Meets Primary Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2671271707","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671271707?lang=en_us&edition=fundamental","pubTime":"2026-09-30 16:14","pubTimestamp":1790756080,"startTime":"0","endTime":"0","summary":"AbbVie's  phase 2 dose-finding study of zumilokibart in adults with moderate-to-severe atopic dermatitis met its primary endpoint, with all three dose regimens achieving \"significantly\" higher response rates at week 16, compared with placebo, the company said Wednesday.The mid-dose regimen has been selected for phase 3 development.The findings support further evaluation of the drug's efficacy, safety and extended dosing intervals as a potential long-term treatment option, AbbVie said.Atopic dermatitis is a condition that causes dry, itchy and inflamed skin.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B2B36J28.USD","IE00BVYPNW00.USD","BK4534","LU0820561909.HKD","LU0456855351.SGD","TRUH","IE00BFTCPJ56.SGD","LU0708994859.HKD","AGNG","LU2357305700.SGD","RXL","LU0256863811.USD","LU0511384066.AUD","LU1983299246.USD","VHT","IE000SO60NU8.SGD","FTXH","LU1732800096.USD","IYH","BK4550","LU0965509010.AUD","LU0211328371.USD","IE000WAW04H5.SGD","IE00BJJMRZ35.SGD","LU0965509101.SGD","IXJ","LU1585245621.USD","LU1003077747.HKD","MEDX","LU1934455863.HKD","LU2023251221.USD","PJP","LU1720051017.SGD","IE00BJT1NW94.SGD","PPH","LU1496350171.SGD","LU0069063385.USD","SG9999015945.SGD","BK4588","LU0289739343.SGD","IE00BSNM7G36.USD","LU0943347566.SGD","FHLC","GLAM","XLV","LU1670628061.USD","IE0009355771.USD","JDOC","ABBV","IE00BDGV0183.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671220206","title":"Abbvie Highlights Positive Results from the Phase 2 Apex Part B Study of Zumilokibart in Moderate to Severe Atopic Dermatitis, as a Late Breaker at Eadv 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671220206","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671220206?lang=en_us&edition=fundamental","pubTime":"2026-09-30 13:30","pubTimestamp":1790746200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nTUAFW3VH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0942090050.USD","FHLC","LU1061106388.HKD","LU1496350171.SGD","ABBV","LU0472753341.HKD","VHT","LU2347655156.SGD","LU1670627923.USD","IXJ","LU1718418525.SGD","XLV","LU1929549753.HKD","PJP","LU1720051017.SGD","IE00B4R5TH58.HKD","RXL","JDOC","IE0009355771.USD","GLAM","LU2089284900.SGD","IE00BFTCPJ56.SGD","LU1003077747.HKD","LU1548497426.USD","LU1551013425.SGD","SG9999015986.USD","FTXH","LU2125909593.SGD","LU0949170772.SGD","PPH","LU0170899867.USD","LU1093756325.SGD","LU1162221912.USD","LU1496350502.SGD","MEDX","AGNG","LU0708994859.HKD","LU0738911758.USD","LU2125909247.SGD","TRUH","LU1037948541.HKD","IE00BSNM7G36.USD","IE0002141913.USD","LU0511384066.AUD","IYH","BK4550","BK4581","LU0256863902.USD","IE00BN8TJ469.HKD","LU0820561818.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671220398","title":"AbbVie Presents Phase 2 APEX Part B Data for Zumilokibart in Moderate-to-Severe Atopic Dermatitis at EADV 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671220398","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671220398?lang=en_us&edition=fundamental","pubTime":"2026-09-30 13:01","pubTimestamp":1790744482,"startTime":"0","endTime":"0","summary":"AbbVie presents Phase 2 APEX Part B data for zumilokibart in moderate-to-severe atopic dermatitis at EADV 2026AbbVie flagged new dermatology trial and real-world results slated for presentation at the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL524zqn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2347655073.USD","IYH","FTXH","LU0661504455.SGD","LU1934455277.USD","XLV","LU2129689431.USD","LU1585245621.USD","LU1244550494.USD","LU2237443895.HKD","LU0472753341.HKD","GLAM","LU1934455863.HKD","LU2089284900.SGD","LU2089283258.USD","FHLC","SG9999015952.SGD","IE00B2B36J28.USD","IXJ","LU0689472784.USD","IE00B19Z3581.USD","LU1923622614.USD","MEDX","PJP","VHT","LU2468319806.SGD","LU1291159041.SGD","LU0795875086.SGD","PPH","IE000F7OJYX1.SGD","LU0320765646.SGD","TRUH","LU1074936037.SGD","LU0949170772.SGD","LU0738911758.USD","LU1057294990.SGD","LU0098860793.USD","LU1061106388.HKD","LU0417517546.SGD","LU1718418525.SGD","LU1496350171.SGD","LU2133065610.SGD","JDOC","LU2357627491.SGD","RXL","AGNG","LU2237443382.USD","IE000SO60NU8.SGD","ABBV","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671224004","title":"Eli Lilly reports results from TRIUMPH-2 Phase 3 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2671224004","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671224004?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:10","pubTimestamp":1790719814,"startTime":"0","endTime":"0","summary":"Eli Lilly (LLY) and Company announced detailed results from TRIUMPH-2, a Phase 3 trial evaluating the efficacy and safety of retatrutide, an invest...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eli-lilly-reports-results-from-triumph-2-phase-3-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eli-lilly-reports-results-from-triumph-2-phase-3-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2361044865.SGD","LU1712237335.SGD","SG9999017495.SGD","IXJ","LU1720051017.SGD","LU2063271972.USD","IE00B4JS1V06.HKD","LU0174119429.USD","LU0353189763.USD","LU1629891620.HKD","LU2756315318.SGD","LU0820561909.HKD","LU2023250504.SGD","LU0385154629.USD","SG9999015945.SGD","LU0061475181.USD","VHT","LU2111349929.HKD","LU1983299246.USD","LU1974910355.USD","IE0001KFT4U8.USD","LU2746668461.USD","LU0238689110.USD","LU2168564065.EUR","LU0109391861.USD","LU2746668974.SGD","ILDR","LU2552382215.SGD","OZEM","LU1917777945.USD","LU0345770308.USD","IE0009355771.USD","LU1804176565.USD","IE00BWXC8680.SGD","LU0109394709.USD","GDOC","BK4007","CANC","IYH","LU2089284900.SGD","LU0094547139.USD","SG9999014898.SGD","LU1868836757.USD","LU2237443978.SGD","LU1280957306.USD","LU2236285917.USD","LLY","LU0820562030.AUD","LU0323591593.USD","LU2491050071.SGD","LU2602419157.SGD","LU0640476718.USD","SG9999001176.USD","LU0256863902.USD","IE00B1BXHZ80.USD","LU2023250330.USD","LU2471134879.HKD","LU2168564149.EUR","LU1720051108.HKD","LU0889565916.HKD","LU1814569148.SGD","LU0882574055.USD","LU0158827948.USD","LU2324357040.USD","LU2361045086.USD","LU0320765992.SGD","TRUH","LU0114720955.EUR","IE00BFSS7M15.SGD","SGXZ31699556.SGD","LU1551013342.USD","LU2471134796.USD","IE0004445239.USD","IE00BFTCPJ56.SGD","LU1093756325.SGD","LU2471134523.USD","SG9999018857.SGD","SG9999015986.USD","LU0943347566.SGD","LU1989771016.USD","SG9999014906.USD","XLV","LU2491049909.HKD","LU1127390331.HKD","LU1366192091.USD","LU0058720904.USD","LU0823416689.USD","LU1267930730.SGD","BK4588","LU1061106388.HKD","LU2023251221.USD","LU2552382132.HKD","LLYX","IE00B4R5TH58.HKD","LU0006306889.USD","SGXZ57979304.SGD","LU0122379950.USD","LU0354030511.USD","LU2237443549.SGD","IE00BK4W5L77.USD","THNR","LU0823434740.USD","CURE","LLII","LU0786609619.USD","LU0096364046.USD","LU2237443622.USD","ELIS","LU0689472784.USD","LU0256863811.USD","LU2213496289.HKD","LU2462157665.USD","IE00BJT1NW94.SGD","SG9999014914.USD","WDNA","LU1979441026.SGD","LU2461242641.AUD","LU2896262040.SGD","IE00B7KXQ091.USD","LU0158827781.USD","PPH","JDOC","LU2271345857.HKD","LU2089283258.USD","LU2237443382.USD","LU2552382058.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0471298777.SGD","LU0787776722.HKD","LU0823434583.USD","SG9999015952.SGD","LU1093756168.USD","LU1323610961.USD","LU0708995401.HKD","LU2360106947.USD","SG9999018865.SGD","LU0198837287.USD","LU2264538146.SGD","LU2750360997.AUD","LU2471134952.CNY","IE00BKPKM429.USD","IE00BKDWB100.SGD","LU1551013425.SGD","SG9999014880.SGD","LU0432979614.USD","LU2112291526.USD","LU0316494557.USD","BK4534","MEDX","RXL","SGXZ99366536.SGD","LLYZ","LU1868837300.USD","BK4581","LU0289739699.SGD","FHLC","LU1145028129.USD","LU2456880835.USD","IE00BK4W5M84.HKD","LU2265009873.SGD","LU1232071149.USD","ELIL","LU2237443895.HKD","LU2468319806.SGD","LU1868836914.USD","LU2462591350.SGD","LU2750360641.GBP","PJP","MHIP","LU2168563687.JPY","FTXH","LU0345770993.USD","IE00B775H168.HKD","SG9999015978.USD","LU0133085943.USD","LU0683600562.USD","LU2237438978.USD","LU1868836591.USD","BK4516","IE00BJJMRX11.SGD","LU0106261372.USD","LU0210536198.USD","TMED","LU1868837136.USD","LU0466842654.USD","LU0320765059.SGD","LU2756315664.SGD","SG9999001176.SGD","IE0004445015.USD","LU0097036916.USD","LU2491050154.USD","LU2168564222.USD","LU1064131342.USD","LU0353189680.USD","LU0672654240.SGD","LU2089984988.USD","LU1548497426.USD","LU0354030438.USD","LU0266013472.USD","BK4599","IE00B1XK9C88.USD","SGXZ81514606.USD","LU1069344957.HKD","BK4585","LU0203202063.USD","LU0882574139.USD","LU1035775433.USD","LU0203201768.USD","IE0002141913.USD","BK4533","LU0820561818.USD","LU1691799644.USD","IE00BN29S564.USD","LU2028103732.USD","HRTS","LU2357305700.SGD","LU2361044949.HKD","LU0964807845.USD","GB00BDT5M118.USD","LU2211815571.USD","MEDI","LU0079474960.USD","LU0456855351.SGD","SGXZ51526630.SGD","LU1057294990.SGD","IHE","LU2168564495.EUR","LU1623119135.USD","LU2417539215.USD","LU2108987350.USD","IE00BJJMRY28.SGD","LU0417517546.SGD","AGNG","LU1291159041.SGD","LU1988902786.USD","LU2106854487.HKD","SG9999013999.USD","IE00BJLML261.HKD","LU0234572021.USD","LU0471298694.HKD","IE00BFSS8Q28.SGD","LU2237443465.HKD","IE0005OL40V9.USD","LU1023059063.AUD","LU2087625088.SGD","LU0225283273.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671402792","title":"Lilly's Experimental Drug Cuts Weight by 21% in Diabetes Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2671402792","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671402792?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:06","pubTimestamp":1790719599,"startTime":"0","endTime":"0","summary":"Lilly's experimental drug cuts weight by 21% in diabetes trialSept 29 (Reuters)-Eli LillyLLY.Nsaid on Tuesday its experimental drug helped adults with type 2 diabetes and obesity lose an average of nearly 21% of their body weight in a late-stage clinical trial.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nL4N45L216:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0006306889.USD","ELIS","GB00BDT5M118.USD","LU0203202063.USD","LU2552382215.SGD","LU2089283258.USD","LU0094547139.USD","LU0672654240.SGD","LU1720051108.HKD","LLY","LU2361044865.SGD","LU0466842654.USD","LU0683600562.USD","IXJ","XLV","LU0106261372.USD","LU1064131342.USD","SG9999015986.USD","LU0122379950.USD","LU2491049909.HKD","LU2211815571.USD","LU2461242641.AUD","BK4599","IE00B1BXHZ80.USD","IE00BWXC8680.SGD","LU2106854487.HKD","LU1093756168.USD","IE00B4JS1V06.HKD","LU0354030438.USD","SG9999018857.SGD","LU2237443895.HKD","LU1979441026.SGD","RXL","LU0234572021.USD","LU0820561909.HKD","LU1814569148.SGD","ELIL","LU0210536198.USD","LU0417517546.SGD","LU2237443622.USD","LU2417539215.USD","LU2750360997.AUD","SG9999001176.SGD","LU0964807845.USD","LU2468319806.SGD","SGXZ51526630.SGD","LU0198837287.USD","LU1366192091.USD","LU2237443465.HKD","LU2471134796.USD","LU1127390331.HKD","LU2456880835.USD","LU0823416689.USD","IE00B4R5TH58.HKD","LU2462591350.SGD","LU0882574055.USD","LU0689472784.USD","SG9999001176.USD","LU1804176565.USD","IE00B2B36J28.USD","CURE","IE00BFSS8Q28.SGD","LU2168563687.JPY","LU2746668461.USD","LU2111349929.HKD","LU2357305700.SGD","LU0786609619.USD","LU0787776722.HKD","LU2168564149.EUR","LU2756315318.SGD","SG9999015952.SGD","FHLC","IE00BKPKM429.USD","IE00BJT1NW94.SGD","LU0097036916.USD","LU2023250330.USD","LU2237438978.USD","IE0004445015.USD","LU0133085943.USD","LU0203201768.USD","LU2237443549.SGD","LU2491050154.USD","LU0061475181.USD","BK4585","BK4588","LU0316494557.USD","SGXZ31699556.SGD","IE00BK4W5M84.HKD","IE0004445239.USD","LU1691799644.USD","LU1712237335.SGD","SGXZ57979304.SGD","LU2028103732.USD","IE0001KFT4U8.USD","LU2471134879.HKD","WDNA","LU0114720955.EUR","LU0158827781.USD","IE00BK4W5L77.USD","LU2063271972.USD","LU1629891620.HKD","LU1983299246.USD","GDOC","OZEM","IE0005OL40V9.USD","LU2602419157.SGD","IHE","LU2552382132.HKD","LU2360106947.USD","IE0009355771.USD","LU0820562030.AUD","LU2462157665.USD","LU1548497426.USD","LU1551013425.SGD","IE00BJJMRZ35.SGD","LU2213496289.HKD","LU1868837136.USD","LU1232071149.USD","LU2746668974.SGD","LU1868836757.USD","MEDX","LU0256863902.USD","LU0432979614.USD","LU1093756325.SGD","LU1323610961.USD","LU1868836914.USD","LU2168564222.USD","IE00BN29S564.USD","LU1057294990.SGD","FTXH","IE00BJJMRX11.SGD","IE00BJJMRY28.SGD","LU2168564495.EUR","LU0882574139.USD","LU1917777945.USD","LU0820561818.USD","SGXZ81514606.USD","LU0456855351.SGD","TMED","LU0345770993.USD","LU1061106388.HKD","LU1720051017.SGD","LU2089984988.USD","LU2265009873.SGD","LU2089284900.SGD","LU2237443382.USD","MEDI","IE00BFSS7M15.SGD","SG9999018865.SGD","THNR","LU0943347566.SGD","LU2168564065.EUR","LU1974910355.USD","HRTS","LU0096364046.USD","LU0385154629.USD","LU1623119135.USD","LU2237443978.SGD","LU0238689110.USD","LU1145028129.USD","LU2471134523.USD","PJP","LU0823434583.USD","BK4534","IE0002141913.USD","SGXZ99366536.SGD","LU2271345857.HKD","LU2023250504.SGD","AGNG","MHIP","SG9999014898.SGD","LU2756315664.SGD","SG9999015978.USD","ILDR","JDOC","LU0320765992.SGD","LU2491050071.SGD","LU1035775433.USD","LU1023059063.AUD","TRUH","LU1868836591.USD","LU0058720904.USD","IE00B1XK9C88.USD","LU2236285917.USD","LU2896262040.SGD","LU1551013342.USD","LU2324357040.USD","IE00B7KXQ091.USD","LU0823434740.USD","LU1989771016.USD","LU1988902786.USD","SG9999014914.USD","LLII","LU2552382058.USD","LU1069344957.HKD","LU1267930730.SGD","LU0353189680.USD","SG9999013999.USD","IYH","LU0471298694.HKD","LU0174119429.USD","LU1291159041.SGD","IE00BJLML261.HKD","IE00BKDWB100.SGD","LU0079474960.USD","LU2023251221.USD","LU2750360641.GBP","LU0320765059.SGD","BK4007","LU0471298777.SGD","LU2087625088.SGD","LLYX","LU0889565916.HKD","BK4533","LU2112291526.USD","BK4581","LU2361045086.USD","LU0708995401.HKD","LU2361044949.HKD","VHT","LU0640476718.USD","LU0323591593.USD","LU0109394709.USD","LU0345770308.USD","SG9999014906.USD","LU1280957306.USD","SG9999014880.SGD","LU0354030511.USD","IE00B775H168.HKD","LU0158827948.USD","LU0225283273.USD","CANC","LU0353189763.USD","BK4516","SG9999015945.SGD","LU0109391861.USD","LLYZ","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU1868837300.USD","LU2108987350.USD","LU0266013472.USD","LU2264538146.SGD","LU2471134952.CNY","SG9999017495.SGD","LU0256863811.USD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671446240","title":"Eli Lilly - Retatrutide 12 Mg Results in 49.6 Lb (20.8%) Weight Loss over 80 Weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2671446240","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671446240?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:00","pubTimestamp":1790719224,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L1YN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2023250504.SGD","LU2361044865.SGD","SGXZ81514606.USD","LU2750360997.AUD","BK4534","IE00BKDWB100.SGD","LU2360106947.USD","LU2896262040.SGD","LU0823416689.USD","LU0061475181.USD","LU0122379950.USD","LU0198837287.USD","BK4581","GB00BDT5M118.USD","IE00BK4W5L77.USD","LU1720051017.SGD","SGXZ51526630.SGD","SGXZ31699556.SGD","CANC","LU2236285917.USD","LU0266013472.USD","LU0353189680.USD","HRTS","LU0158827781.USD","IE00BJT1NW94.SGD","LU0225283273.USD","LU2462591350.SGD","IXJ","IE00B1BXHZ80.USD","LU0432979614.USD","LU2168564222.USD","LU1551013342.USD","LU1983299246.USD","LU0345770308.USD","LU1917777945.USD","IE00B2B36J28.USD","IE0002141913.USD","IE00BWXC8680.SGD","LU0345770993.USD","CURE","LU2417539215.USD","LU1035775433.USD","IE00B1XK9C88.USD","LU0787776722.HKD","TMED","SG9999015945.SGD","AGNG","BK4588","IE00BKPKM429.USD","LU2237443382.USD","LU0820562030.AUD","LU2265009873.SGD","LU1868836757.USD","SG9999014880.SGD","LU2746668461.USD","LU1691799644.USD","LU0320765992.SGD","LU1551013425.SGD","BK4007","XLV","LU2461242641.AUD","SG9999013999.USD","LU2756315318.SGD","LU0238689110.USD","SGXZ57979304.SGD","BK4599","LU2111349929.HKD","LU2112291526.USD","FTXH","LU0820561909.HKD","LU2211815571.USD","LU2471134952.CNY","LU0640476718.USD","LU0683600562.USD","LU2361045086.USD","LU0889565916.HKD","LU1548497426.USD","SG9999017495.SGD","LU1814569148.SGD","LU1868836591.USD","LU1974910355.USD","WDNA","LU1868836914.USD","IE00B4JS1V06.HKD","LU0256863811.USD","LU1868837136.USD","LU2491050154.USD","LU1720051108.HKD","SG9999014906.USD","LU1804176565.USD","IE00BK4W5M84.HKD","LU0943347566.SGD","IE00BFSS7M15.SGD","SG9999018857.SGD","BK4533","PPH","LU0354030511.USD","LU2237438978.USD","LU1989771016.USD","LU0471298694.HKD","LU2552382058.USD","IE00BJJMRY28.SGD","IE0005OL40V9.USD","LU0109391861.USD","LU0354030438.USD","LU1623119135.USD","ELIL","LU0133085943.USD","LU2089284900.SGD","LU1868837300.USD","LU2213496289.HKD","BK4516","LU2468319806.SGD","LU2237443549.SGD","LLY","LU2471134879.HKD","THNR","LU0114720955.EUR","LU1069344957.HKD","LU1323610961.USD","LU2168564149.EUR","IE00BJJMRX11.SGD","LU2491050071.SGD","LU2089984988.USD","LU1064131342.USD","IE00BJLML261.HKD","LU2168564495.EUR","LU0234572021.USD","GDOC","IE00BFTCPJ56.SGD","LU2106854487.HKD","LU0174119429.USD","LU2750360641.GBP","LU2456880835.USD","LU1127390331.HKD","LU0708995401.HKD","TRUH","SG9999014898.SGD","LU1057294990.SGD","LU2168563687.JPY","LU0079474960.USD","LLII","IE00B4R5TH58.HKD","LU1712237335.SGD","LU0417517546.SGD","SGXZ99366536.SGD","LU1988902786.USD","LU2357305700.SGD","PJP","LU0820561818.USD","LU2237443978.SGD","IE00BJJMRZ35.SGD","LU1145028129.USD","LU2602419157.SGD","LU0385154629.USD","LU2462157665.USD","MEDI","JDOC","LU2089283258.USD","IE0001KFT4U8.USD","LU0289739699.SGD","LU2063271972.USD","LU2108987350.USD","IE0004445015.USD","ILDR","LU0316494557.USD","LU1093756325.SGD","LU2264538146.SGD","LLYZ","LU0096364046.USD","LLYX","LU0094547139.USD","LU0471298777.SGD","LU0823434583.USD","LU1093756168.USD","IE0004445239.USD","LU0964807845.USD","MHIP","LU0256863902.USD","LU2237443895.HKD","LU1629891620.HKD","LU0106261372.USD","LU1232071149.USD","ELIS","LU0323591593.USD","LU0882574055.USD","LU2023250330.USD","LU2271345857.HKD","LU0456855351.SGD","IHE","LU0006306889.USD","LU0320765059.SGD","LU0672654240.SGD","LU1366192091.USD","LU2028103732.USD","LU1280957306.USD","LU0466842654.USD","LU2552382132.HKD","LU0882574139.USD","LU2168564065.EUR","IE00BFSS8Q28.SGD","SG9999015986.USD","LU2237443465.HKD","LU0097036916.USD","LU0689472784.USD","LU2087625088.SGD","LU2471134523.USD","VHT","LU0058720904.USD","BK4585","IYH","LU0353189763.USD","LU1291159041.SGD","LU1979441026.SGD","LU1061106388.HKD","LU0823434740.USD","LU1267930730.SGD","LU2324357040.USD","LU0203201768.USD","LU2746668974.SGD","MEDX","IE00B7KXQ091.USD","IE00B775H168.HKD","OZEM","LU0203202063.USD","SG9999001176.USD","SG9999015978.USD","FHLC","SG9999014914.USD","LU2552382215.SGD","LU2361044949.HKD","LU2756315664.SGD","LU2023251221.USD","LU0109394709.USD","LU2237443622.USD","LU2491049909.HKD","RXL","LU1023059063.AUD","LU0158827948.USD","SG9999015952.SGD","SG9999018865.SGD","SG9999001176.SGD","IE00BN29S564.USD","LU0786609619.USD","IE0009355771.USD","LU2471134796.USD","LU0210536198.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671240445","title":"Lilly's Triple Agonist, Retatrutide, Delivered Substantial Weight Loss and A1c Reduction, Underscoring Its Potential Promise for People with Obesity and Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2671240445","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671240445?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:00","pubTimestamp":1790719224,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L1YN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0266013472.USD","IE00BK4W5L77.USD","LU0106261372.USD","LU0354030438.USD","LU1623119135.USD","LU2089984988.USD","LU2213496289.HKD","ILDR","IHE","LU2237443978.SGD","BK4534","IE00BJT1NW94.SGD","MHIP","PPH","IE00BK4W5M84.HKD","LU1551013425.SGD","IE00BFTCPJ56.SGD","LU2456880835.USD","LU2462157665.USD","LU0683600562.USD","LU2462591350.SGD","LU1691799644.USD","LU1720051108.HKD","ELIS","LU0234572021.USD","LU1868836591.USD","MEDX","LU0889565916.HKD","SGXZ51526630.SGD","LU2756315318.SGD","LU0174119429.USD","LU0320765992.SGD","LU2106854487.HKD","LU2361044949.HKD","LU0061475181.USD","CURE","IE00BKPKM429.USD","LLII","LU1814569148.SGD","SG9999015986.USD","IYH","LU0385154629.USD","LU0640476718.USD","LU2112291526.USD","SG9999014880.SGD","LU2089284900.SGD","IE00B7KXQ091.USD","SG9999018865.SGD","LU0122379950.USD","BK4533","LU0114720955.EUR","LU2211815571.USD","LU2089283258.USD","LLY","LU1804176565.USD","LU2491050071.SGD","OZEM","IE00B1BXHZ80.USD","LU2491049909.HKD","LU0353189763.USD","BK4588","LU0882574055.USD","LU1720051017.SGD","IE00BJJMRY28.SGD","LU0109391861.USD","IXJ","WDNA","LU0820561818.USD","LU2471134952.CNY","BK4599","LU1064131342.USD","LU1983299246.USD","LU2491050154.USD","LU2756315664.SGD","LU0256863902.USD","LU0672654240.SGD","LU0210536198.USD","LU1267930730.SGD","LU2471134796.USD","LU2552382058.USD","LU1868836757.USD","IE00BJJMRX11.SGD","SGXZ31699556.SGD","LU1366192091.USD","LU0787776722.HKD","LU2168564065.EUR","LU1712237335.SGD","LU0323591593.USD","LU2602419157.SGD","LU0096364046.USD","LLYX","LU0289739699.SGD","LU0097036916.USD","LU0345770993.USD","LU0345770308.USD","LU0353189680.USD","LU0256863811.USD","LLYZ","LU1023059063.AUD","LU1093756325.SGD","LU0198837287.USD","BK4516","BK4585","LU0058720904.USD","LU0432979614.USD","LU2237443382.USD","SG9999001176.USD","LU2237443465.HKD","LU0689472784.USD","LU2471134523.USD","IE0004445015.USD","LU0823434740.USD","LU0823434583.USD","LU2111349929.HKD","LU2168564149.EUR","LU0238689110.USD","SGXZ99366536.SGD","LU0320765059.SGD","LU0964807845.USD","LU2237438978.USD","LU2746668461.USD","LU2552382215.SGD","CANC","LU0109394709.USD","IE00B2B36J28.USD","LU1323610961.USD","LU2361045086.USD","SGXZ81514606.USD","TMED","LU2023251221.USD","LU0820561909.HKD","SG9999014898.SGD","LU0417517546.SGD","VHT","LU2028103732.USD","AGNG","LU1061106388.HKD","SG9999001176.SGD","FHLC","TRUH","LU0158827948.USD","ELIL","LU0158827781.USD","LU2237443622.USD","LU1629891620.HKD","LU2108987350.USD","LU0943347566.SGD","LU2468319806.SGD","IE00BN29S564.USD","LU2271345857.HKD","LU2063271972.USD","LU2361044865.SGD","HRTS","SG9999015952.SGD","SG9999017495.SGD","IE00B1XK9C88.USD","SG9999014906.USD","SGXZ57979304.SGD","LU2461242641.AUD","LU2552382132.HKD","LU0316494557.USD","LU2023250504.SGD","IE00B4JS1V06.HKD","IE0002141913.USD","PJP","LU0471298694.HKD","LU1127390331.HKD","IE0009355771.USD","LU1280957306.USD","LU1035775433.USD","SG9999015978.USD","LU2023250330.USD","IE0001KFT4U8.USD","IE0005OL40V9.USD","GB00BDT5M118.USD","LU0456855351.SGD","LU0823416689.USD","LU1057294990.SGD","SG9999018857.SGD","LU1868836914.USD","LU1979441026.SGD","LU2746668974.SGD","LU1988902786.USD","LU1989771016.USD","IE00B775H168.HKD","GDOC","LU0471298777.SGD","LU1145028129.USD","LU1868837136.USD","XLV","LU1093756168.USD","SG9999014914.USD","LU2750360997.AUD","LU2168563687.JPY","LU1548497426.USD","LU0786609619.USD","IE0004445239.USD","LU1917777945.USD","LU0203202063.USD","LU0354030511.USD","LU1069344957.HKD","LU1291159041.SGD","LU0094547139.USD","LU2237443549.SGD","LU0882574139.USD","SG9999015945.SGD","LU2417539215.USD","LU2750360641.GBP","BK4581","LU0466842654.USD","IE00BJJMRZ35.SGD","IE00BJLML261.HKD","LU2087625088.SGD","LU2168564495.EUR","JDOC","LU2265009873.SGD","SG9999013999.USD","IE00BFSS7M15.SGD","BK4007","LU2324357040.USD","RXL","LU0079474960.USD","LU2360106947.USD","IE00BFSS8Q28.SGD","LU2896262040.SGD","IE00BKDWB100.SGD","LU0203201768.USD","LU0006306889.USD","LU2236285917.USD","LU0820562030.AUD","LU2471134879.HKD","IE00BWXC8680.SGD","LU1974910355.USD","LU0225283273.USD","THNR","LU1232071149.USD","LU2357305700.SGD","LU2237443895.HKD","IE00B4R5TH58.HKD","LU1551013342.USD","LU0708995401.HKD","LU2264538146.SGD","FTXH","LU2168564222.USD","MEDI","LU0133085943.USD","LU1868837300.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671240410","title":"Eli Lilly - to Submit Biologics License Application for Retatrutide in Q1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2671240410","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671240410?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:00","pubTimestamp":1790719224,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L1YN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","IE00B2B36J28.USD","LU0823434583.USD","LU0316494557.USD","LU0256863902.USD","LU0109394709.USD","IE00BFSS8Q28.SGD","IE00BN29S564.USD","LU0225283273.USD","LU2089283258.USD","LU2211815571.USD","LU0640476718.USD","LU1814569148.SGD","LU2168563687.JPY","LU2271345857.HKD","LU0109391861.USD","LU2023251221.USD","SG9999014898.SGD","LU2471134952.CNY","CURE","LU2750360641.GBP","LU0353189680.USD","LU0823434740.USD","LU0122379950.USD","ELIS","LU0820561818.USD","SG9999018865.SGD","LU0094547139.USD","SG9999013999.USD","LU2168564495.EUR","IE00B775H168.HKD","IE00BFSS7M15.SGD","VHT","LU0079474960.USD","IYH","LU2746668461.USD","LU2756315318.SGD","LU1868836591.USD","LU2087625088.SGD","LU2168564065.EUR","BK4585","LU0006306889.USD","LU0353189763.USD","LU0354030511.USD","LU1979441026.SGD","LU2462157665.USD","IE0001KFT4U8.USD","LU1917777945.USD","LU1035775433.USD","LU2063271972.USD","IE00BJT1NW94.SGD","LU1366192091.USD","IE00B4R5TH58.HKD","ILDR","LU0256863811.USD","BK4581","SG9999018857.SGD","SGXZ31699556.SGD","LLYX","LU1548497426.USD","LU2552382132.HKD","WDNA","LU1323610961.USD","LU2896262040.SGD","FHLC","LU1145028129.USD","LU0203202063.USD","IE00BJLML261.HKD","LU0097036916.USD","SG9999001176.USD","LU0471298777.SGD","LU1720051017.SGD","LU2602419157.SGD","LU2552382058.USD","IE00BKDWB100.SGD","LU1974910355.USD","LU1291159041.SGD","LU2023250330.USD","LU0266013472.USD","LU2023250504.SGD","LLII","LU2111349929.HKD","LU2746668974.SGD","LU0823416689.USD","IXJ","LU0889565916.HKD","LU0964807845.USD","PPH","LU0417517546.SGD","IE00B4JS1V06.HKD","LU0203201768.USD","LLYZ","MEDX","LU0345770308.USD","LU0689472784.USD","LU2456880835.USD","PJP","LU2491050154.USD","LU1868837136.USD","LU1983299246.USD","LU1093756325.SGD","BK4533","LU1551013342.USD","RXL","LU0289739699.SGD","LU0787776722.HKD","THNR","IE00BKPKM429.USD","IE0004445239.USD","LU1064131342.USD","IE00BJJMRY28.SGD","LU0106261372.USD","LU0323591593.USD","LU1232071149.USD","LU2237443978.SGD","HRTS","LU0320765992.SGD","IE00BK4W5L77.USD","LU2756315664.SGD","SG9999001176.SGD","LU2028103732.USD","LU1061106388.HKD","LU1551013425.SGD","ELIL","IE00BFTCPJ56.SGD","LU1069344957.HKD","LU0943347566.SGD","LU1868836914.USD","IE00BK4W5M84.HKD","LU1804176565.USD","MHIP","LU2264538146.SGD","LU2361044865.SGD","LU0456855351.SGD","LU0471298694.HKD","LU2361045086.USD","LU0096364046.USD","LU1720051108.HKD","LU0385154629.USD","LU0882574139.USD","IE0005OL40V9.USD","LU2361044949.HKD","LU2237438978.USD","SG9999014906.USD","JDOC","BK4599","SGXZ99366536.SGD","LU2461242641.AUD","BK4534","LU2324357040.USD","LU2112291526.USD","BK4588","BK4007","LU2750360997.AUD","LU1127390331.HKD","LU2106854487.HKD","LU2236285917.USD","IE00BJJMRX11.SGD","LU0320765059.SGD","IE0004445015.USD","LU1629891620.HKD","CANC","LU0158827948.USD","LU0238689110.USD","LU0345770993.USD","LU1868836757.USD","LU1691799644.USD","SGXZ81514606.USD","LU2468319806.SGD","IE00B7KXQ091.USD","LU0672654240.SGD","BK4516","LU0882574055.USD","TRUH","LU0466842654.USD","LU0786609619.USD","IE00B1BXHZ80.USD","LU1280957306.USD","LU2089984988.USD","LU2237443622.USD","LU0820562030.AUD","LU1712237335.SGD","LU1093756168.USD","LU0114720955.EUR","LU0058720904.USD","LU2213496289.HKD","LU1988902786.USD","LU2491049909.HKD","AGNG","SG9999015986.USD","TMED","LU2168564222.USD","SGXZ51526630.SGD","LU0158827781.USD","LU0234572021.USD","LU0061475181.USD","LU0174119429.USD","LU0354030438.USD","LU2237443465.HKD","LU1057294990.SGD","LU2237443549.SGD","SG9999015978.USD","LU1989771016.USD","LU2471134523.USD","LU0820561909.HKD","LU1267930730.SGD","LU0133085943.USD","SG9999014880.SGD","IE0002141913.USD","LU2108987350.USD","IE00BJJMRZ35.SGD","LU2168564149.EUR","LU2417539215.USD","LU0198837287.USD","LU2471134796.USD","SG9999015945.SGD","LU0210536198.USD","LU2491050071.SGD","IE00B1XK9C88.USD","LU2237443382.USD","LLY","GDOC","IE00BWXC8680.SGD","LU2462591350.SGD","SGXZ57979304.SGD","XLV","LU2089284900.SGD","LU2360106947.USD","SG9999014914.USD","GB00BDT5M118.USD","LU2237443895.HKD","MEDI","LU2357305700.SGD","LU2471134879.HKD","SG9999017495.SGD","LU2265009873.SGD","LU0683600562.USD","LU0708995401.HKD","LU0432979614.USD","LU1623119135.USD","OZEM","SG9999015952.SGD","LU1868837300.USD","LU1023059063.AUD","IHE","LU2552382215.SGD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671240400","title":"Eli Lilly - 59.5% of Retatrutide 12 Mg Participants no Longer Meet Bmi Criteria for Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2671240400","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671240400?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:00","pubTimestamp":1790719224,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L1YN:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2028103732.USD","LU0109391861.USD","LU2111349929.HKD","LU2746668974.SGD","IE00BJJMRZ35.SGD","LU2417539215.USD","LU2471134952.CNY","IE00BJT1NW94.SGD","GDOC","LU0133085943.USD","LU0238689110.USD","LU2236285917.USD","LU0158827948.USD","LU1804176565.USD","WDNA","LU0471298694.HKD","HRTS","FHLC","IE00B775H168.HKD","LU1988902786.USD","LU2108987350.USD","LU0964807845.USD","LU1366192091.USD","LU2361045086.USD","PJP","LU2237443622.USD","IE00BWXC8680.SGD","TRUH","LU1548497426.USD","IE00BJJMRY28.SGD","IE00BFSS8Q28.SGD","BK4533","LU1814569148.SGD","LU2237443895.HKD","LU0345770993.USD","LU1623119135.USD","LU2237443549.SGD","LU0096364046.USD","LU0079474960.USD","LU0353189763.USD","LU1983299246.USD","PPH","LU0094547139.USD","LU0823434740.USD","LU1974910355.USD","SG9999015945.SGD","BK4007","SGXZ57979304.SGD","LLY","LLII","IE0004445015.USD","LU2211815571.USD","LU1267930730.SGD","LU0640476718.USD","LU0456855351.SGD","SG9999013999.USD","IE00B2B36J28.USD","IE00BK4W5L77.USD","LU1868837136.USD","LU2602419157.SGD","IE0004445239.USD","LU2461242641.AUD","RXL","IE00BJJMRX11.SGD","LU1069344957.HKD","LU0174119429.USD","MHIP","LU2361044949.HKD","IE00BFTCPJ56.SGD","LU0823416689.USD","LU1093756325.SGD","LU2756315664.SGD","SGXZ51526630.SGD","LU0114720955.EUR","IE00BN29S564.USD","LU0122379950.USD","LU1868836757.USD","LU2491050071.SGD","VHT","LU1720051108.HKD","OZEM","LU2491049909.HKD","LU0708995401.HKD","LU2168563687.JPY","THNR","LU1989771016.USD","LU2237438978.USD","LU2552382132.HKD","LU0097036916.USD","LU1691799644.USD","LU0882574139.USD","LU1291159041.SGD","LU0210536198.USD","FTXH","LU0354030511.USD","LU2087625088.SGD","LLYX","LU0882574055.USD","LU0106261372.USD","SGXZ81514606.USD","LU2237443465.HKD","LU0198837287.USD","IE00B7KXQ091.USD","LU1868836914.USD","LU0109394709.USD","LU0225283273.USD","LU1280957306.USD","LU2089984988.USD","IXJ","LU2896262040.SGD","IE00BKPKM429.USD","LU2756315318.SGD","LU1035775433.USD","LU0320765059.SGD","LU0471298777.SGD","SG9999014914.USD","LU1979441026.SGD","SGXZ99366536.SGD","LU2023250330.USD","IE0002141913.USD","SG9999001176.USD","LU0158827781.USD","BK4599","LU2271345857.HKD","LU2468319806.SGD","LLYZ","IE00BFSS7M15.SGD","BK4534","IE0001KFT4U8.USD","LU1868836591.USD","LU0289739699.SGD","MEDI","SG9999014898.SGD","SG9999017495.SGD","LU1868837300.USD","GB00BDT5M118.USD","LU0320765992.SGD","LU2750360997.AUD","LU2456880835.USD","LU0385154629.USD","LU0786609619.USD","LU0266013472.USD","LU0316494557.USD","LU2168564065.EUR","LU0345770308.USD","LU2106854487.HKD","BK4581","SG9999015978.USD","LU0787776722.HKD","TMED","XLV","LU2462591350.SGD","SG9999001176.SGD","LU0943347566.SGD","LU2168564222.USD","LU2471134523.USD","MEDX","BK4585","IE00BK4W5M84.HKD","LU0256863811.USD","LU0256863902.USD","IHE","LU2112291526.USD","LU2168564495.EUR","LU2552382215.SGD","LU1093756168.USD","BK4588","LU2324357040.USD","LU2471134796.USD","IE00BKDWB100.SGD","LU2264538146.SGD","IYH","LU0058720904.USD","SG9999014880.SGD","LU2471134879.HKD","LU1917777945.USD","LU2063271972.USD","LU2237443382.USD","LU0061475181.USD","LU1023059063.AUD","LU1057294990.SGD","LU0820561818.USD","LU2023250504.SGD","LU0689472784.USD","IE00B4R5TH58.HKD","LU0353189680.USD","LU0823434583.USD","LU1720051017.SGD","IE00BJLML261.HKD","LU1551013342.USD","LU2237443978.SGD","LU0006306889.USD","LU1145028129.USD","LU2089284900.SGD","LU1551013425.SGD","IE0005OL40V9.USD","ELIL","LU0203202063.USD","LU0203201768.USD","LU1127390331.HKD","ELIS","LU2491050154.USD","LU0432979614.USD","SG9999018865.SGD","IE0009355771.USD","LU2360106947.USD","BK4516","LU2023251221.USD","ILDR","LU0417517546.SGD","LU0323591593.USD","LU2750360641.GBP","SGXZ31699556.SGD","LU2168564149.EUR","LU0820561909.HKD","LU0234572021.USD","LU0683600562.USD","LU1712237335.SGD","LU2746668461.USD","LU2265009873.SGD","LU0672654240.SGD","SG9999014906.USD","SG9999015952.SGD","SG9999018857.SGD","LU0354030438.USD","LU1629891620.HKD","LU2213496289.HKD","LU2361044865.SGD","CURE","LU2462157665.USD","JDOC","CANC","LU0889565916.HKD","LU2552382058.USD","LU1061106388.HKD","LU1232071149.USD","IE00B4JS1V06.HKD","LU2089283258.USD","LU1323610961.USD","SG9999015986.USD","LU0820562030.AUD","IE00B1BXHZ80.USD","LU2357305700.SGD","LU1064131342.USD","AGNG","LU0466842654.USD","IE00B1XK9C88.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":18,"pageCount":6,"totalSize":347,"code":"91000000","status":"200"}]}}